Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
Is a |
pramoxinhydrochlorid |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pramocaine hydrochloride |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
Is a |
hydrocortisonacetat + pramoxinhydrochlorid |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone (substance) |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
binyrehormonmiddel |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone acetate |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
Has manufactured dose form |
kutan OG/ELLER transdermal doseringsform |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
Is a |
Product containing hydrocortisone and pramocaine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
Is a |
hydrocortisonpræparat til topikal anvendelse |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
Is a |
Product containing pramocaine in topical dosage form |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
Has manufactured dose form |
lotion |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
Is a |
Product containing hydrocortisone acetate |
false |
Inferred relationship |
Some |
|
|